FLU A+B Nasal Swab Clinical Study

Completed

Conditions studied: Influenza

In brief

The purpose of this clinical study is to obtain clearance for the nasal swab sample type by demonstrating the performance characteristics of the FLU A+B Test versus standard laboratory culture for Influenza A and B viruses using nasal swab samples.

Key facts

Study ID

NCT00636662

Run by

Response Biomedical Corp.

People needed

800

Starts

2008-02-01

Expected to finish

2008-05-01

Last updated by the study team

2019-03-27

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and Female of all age groups
• Patients exhibiting influenza symptoms (i.e., fever, body aches, headaches, cough, sore throat, and other respiratory symptoms) at the time of examination
• Patients must either present with a fever (>100ºF; >37.8ºC) at time of examination or have had a fever (>100ºF; >37.8ºC) or declare at time of the examination that they had a fever within the previous 3 days prior to the examination
• Must be able to collect sample using the nasal swab sample type

You may not qualify if…

• Patients with no fever at time of examination or within the 3 days prior to examination and/or are currently undergoing treatment (including anti-virals) will be excluded from the study.

Where it is running

• Northwestern University — Chicago, Illinois, United States
• Washington University / St. Louis Children's Hospital — St Louis, Missouri, United States
• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States
• Dell Children's Hospital — Austin, Texas, United States
• Mt. Sinai Hospital — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.